DALLE CARBONARE, Luca Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 5.566
NA - Nord America 5.519
AS - Asia 4.401
OC - Oceania 31
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 10
Totale 15.561
Nazione #
US - Stati Uniti d'America 5.479
CN - Cina 3.641
GB - Regno Unito 2.073
IT - Italia 842
SE - Svezia 560
FR - Francia 443
IE - Irlanda 440
RU - Federazione Russa 363
DE - Germania 314
FI - Finlandia 282
SG - Singapore 269
VN - Vietnam 151
TR - Turchia 113
UA - Ucraina 106
KR - Corea 54
BE - Belgio 44
JP - Giappone 39
AU - Australia 31
CA - Canada 30
IR - Iran 28
HK - Hong Kong 26
IN - India 22
NL - Olanda 20
CZ - Repubblica Ceca 14
AT - Austria 12
TW - Taiwan 11
ES - Italia 9
EU - Europa 8
CL - Cile 7
LV - Lettonia 7
MY - Malesia 7
IL - Israele 6
PL - Polonia 6
AM - Armenia 5
CH - Svizzera 5
PK - Pakistan 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
BR - Brasile 4
DK - Danimarca 4
HU - Ungheria 4
NO - Norvegia 4
PE - Perù 4
BD - Bangladesh 3
ID - Indonesia 3
KZ - Kazakistan 3
MA - Marocco 3
PA - Panama 3
PR - Porto Rico 3
AZ - Azerbaigian 2
EG - Egitto 2
HR - Croazia 2
LT - Lituania 2
MX - Messico 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
EC - Ecuador 1
GR - Grecia 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 15.561
Città #
Southend 1.924
Chandler 1.157
Jacksonville 797
Dublin 435
Verona 393
Woodbridge 376
Ann Arbor 338
Ashburn 306
New York 288
Beijing 283
Houston 283
Singapore 172
Princeton 165
Lawrence 164
Wilmington 163
Jinan 155
Nanjing 151
Shenyang 118
Dong Ket 97
Helsinki 84
Sindelfingen 71
Hebei 69
Tianjin 64
Boardman 61
Changsha 57
Haikou 57
Ningbo 52
Nanchang 50
Redmond 49
Seoul 45
Brussels 44
Zhengzhou 44
Taizhou 43
Hangzhou 42
Jiaxing 40
Lancaster 39
Seattle 36
Taiyuan 36
Milan 32
Tokyo 30
Los Angeles 29
Fuzhou 28
Guangzhou 28
Falls Church 27
Norwalk 26
Redwood City 22
Rome 21
Sant'Ambrogio di Valpolicella 20
San Francisco 19
Dallas 17
Toronto 17
Detroit 16
Lanzhou 16
Bologna 15
Auburn Hills 14
Fairfield 14
Washington 14
Hong Kong 13
Kent 13
Leawood 13
Brisbane 12
Cambridge 12
Chicago 11
Dearborn 11
London 11
St Petersburg 11
Cagliari 10
Phoenix 10
Vienna 10
Brno 8
Düsseldorf 8
Kemerovo 8
New Taipei 8
Padova 7
San Mateo 7
Tombolo 7
Clearwater 6
Des Moines 6
Dongguan 6
Elora 6
Olomouc 6
Riva 6
Stuttgart 6
Trento 6
Amsterdam 5
Esslingen am Neckar 5
Florence 5
Lappeenranta 5
Las Vegas 5
Novokuznetsk 5
Renton 5
Yerevan 5
Augusta 4
Canberra 4
Kuala Lumpur 4
Lima 4
Melbourne 4
Monmouth Junction 4
Newark 4
Palermo 4
Totale 9.463
Nome #
CRISPR/Cas9 mediated knock-out of RUNX2 in melanoma cells 1.208
CRISPR/Cas9 genome editing in melanoma cells: new insight of RUNT domain 1.189
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 181
Effects of Duplex-specific nuclease on human cells expression profiling using RNA-seq 178
Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL β-trefoil 152
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 144
Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction 137
Ascorbic Acid Induces either Differentiation or Apoptosis in MG-63 Osteosarcoma Lineage 137
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 134
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 133
Increased glutaminyl cyclase expression in peripheral blood of Alzheimer's Disease patients. 127
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 126
Lack of expression of SERPINF1, the gene coding for pigment epithelium derived factor, causes progressively deforming Osteogenesis Imperfecta with normal type I collagen 124
An integrated approach identifies new oncotargets in melanoma 123
STEAP mRNA detection in serum of patients with solid tumours. 121
Bone density and skeletal metabolism in patients with orthotopic ileal neobladder. 120
Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis 120
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 118
A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect 117
Can half-marathon affect overall health? The yin-yang of sport 116
Runx2 mRNA Expression in the Tissue, Serum, and Circulating Non-Hematopoietic Cells of Patients with Thyroid Cancer. 115
OSTEONECROSI, OSTEOSCLEROSI ED ALTRI DISORDINI DELL’OSSO 114
BONE HISTOMORPHOMETRY IN UNTREATED AND TREATED GLUCOCORTICOID-INDUCED OSTEOPOROSIS (GIO) 110
Differential characteristics of bone quality and bone turnover biochemical markers in patients with hip fragility fractures and hip osteoarthritis: results of a clinical pilot study. 110
Hypophosphatasia and mesenchymal stem cells: a therapeutic promise 110
A Novel Splicing Mutation in FKBP10 in a patient with a moderate Osteogenesis Imperfecta histologically classificable as type VI 109
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 107
Molecular Approaches To Target GPCRs in Cancer Therapy 107
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 106
Defects of SERPINF1 cause progressively deforming recessive osteogenesis imperfecta with normal Collagen I 106
Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients. 105
Bone microarchitecture as an important determinant of bone strength. 104
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. 102
Clodronate as a Therapeutic Strategy against Osteoarthritis 101
The Runt domain of RUNX2 induces the migration of melanoma cells to bone 99
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 97
METODO PER LA RILEVAZIONE DI GALFA15 COME MARCATORETUMORALE NEL CARCINOMA PANCREATICO 96
Il profilo del clodronato nel trattamento dell’osteoporosi 96
Bone Fragility in Acromegalic Patients: A Mystery Almost Solved? 96
Atypical femoral fracture as first sign of non-hodgkin lymphoma- case report with a brief review of the literature 96
Bone histomorphometry in acromegaly patients with fragility vertebral fractures 96
A potential role of RUNX2- RUNT domain in modulating the expression of genes involved in bone metastases: an in vitro study with melanoma cells 96
Runx-2 gene expression is associated with age-related changes of bone mineral density in the healthy young-adult population 96
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 95
Runx2 stimulates neoangiogenesis through the Runt domain in melanoma 95
Runx2 expression: A mesenchymal stem marker for cancer 95
Bone Microarchitecture in Mild Primary Hyperparathyroidism 94
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 94
Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. 94
Transcription Factor Runx2 and its Application to Bone Tissue Engineering. 94
Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients 94
Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells. 93
Presentation and Outcome of Pancreaticoduodenal Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome 93
Effects of intense physical exercise on osteogenic commitment of mesenchymal progenitors 93
C-met inhibition blocks bone metastasis development induced by renal cancer stem cells. 93
Bone microarchitecture evaluated by histomorphometry 92
Zoledronic acid decreases mRNA STEAP expression in prostate cancer cells 92
Telomerase mRNA detection in serum of patients with prostate cancer 92
Clodronate as a Therapeutic Strategy against Osteoarthritis 91
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 90
ALENDRONATE PREVENTS FURTHER BONE LOSS IN RENAL TRANSPLANT RECIPIENTS 90
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 89
Enhanced osteogenic differentiation in Zoledronate-treated osteoporotic patients 89
Continuous and cyclical clodronate therapies and bone density in postmenopausal bone loss. 88
Runx2 overexpression compromises bone quality in acromegalic patients 88
New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration 88
Bisfosfonati e metastasi ossee:up-to-date 2005 87
Corsetto monovalva in plastica rinfrozato posteriormente con stecche incarbonio 86
Multifocal osteonecrosis in a patient with anamnestic ulcerative colitis. Is there a relationship with the disease and the use of glucocorticoids twenty years before? A brief review of the literature 85
Vitamin D: Daily vs. Monthly Use in Children and Elderly-What Is Going On? 85
Effects of oral anticoagulant therapy on gene expression in crosstalk between osteogenic progenitor cells and endothelial cells 85
Bone disease in primary hypercalciuria. 84
Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. 84
Histomorphometric analysis of glucocorticoid-induced osteoporosis 83
MINIMALLY INVASIVE RADIOGUIDED PARATHYROIDECTOMY: AN ATTRACTIVE THERAPEUTIC OPTION FOR ELDERLY PATIENTS WITH PRIMARY HYPERPARATHYROIDISM 82
Gα15 in early onset of pancreatic ductal adenocarcinoma 82
Bone histomorphometry in untreated and treated glucocorticoid-induced osteoporosis. 81
First case of bloodstream infection due to Candida magnoliae in a Chinese oncological patient. 80
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 79
Novel Splicing Mutation in FKBP10 gene in a patient with moderate-severe form of Osteogenesis imperfecta 79
Mesenchymal stem cells: A new diagnostic tool? 79
Fast method for skeletal tissue gene expression analysis. 79
L’OSTEOPOROSI DA TRAPIANTO D’ORGANO 78
Circulating progenitor stem cells are important biomarkers of chondrogenesis and osteogenesis: employment in diagnosis and treatment follow up 78
BEL β‐Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted Zebrafish 78
Osteogenic differentiation in healthy and pathological conditions 78
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 77
VERTEBRAL MORPHOMETRY BY X-RAY ABSORPTIOMETRY BEFORE AND AFTER LIVER TRANSPLANT: A CROSS-SECTIONAL STUDY 77
Densitometric threshold and vertebral fractures in heart transplant patients 77
Physical activity prevents cartilage degradation: a metabolomics study pinpoints the involvement of vitamin B6 77
Presentation, diagnostic features and glucose handling in a monocentric series of insulinomas 76
Vitamin D Daily versus Monthly Administration: Bone Turnover and Adipose Tissue Influences 76
Vitamin K, vertebral fractures, vascular calcifications and mortality: Vitamin K Italian (VIKI) dialysis study. 75
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 74
[Bone biopsy in the Chronic Kidney Disease (CKD)] 74
Interference from immunocomplexes on a high-sensitivity cardiac troponin T immunoassay 74
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 74
Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis. 73
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management. 73
GNAS Mutations: Drivers or Co-Pilots? Yet, Promising Diagnostic Biomarkers 73
Totale 11.977
Categoria #
all - tutte 48.024
article - articoli 39.099
book - libri 266
conference - conferenze 6.924
curatela - curatele 0
other - altro 0
patent - brevetti 468
selected - selezionate 0
volume - volumi 1.267
Totale 96.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.146 0 0 18 91 146 113 157 92 58 188 103 180
2020/20211.500 179 220 80 171 164 132 30 93 79 23 157 172
2021/20221.644 141 491 25 173 34 54 25 77 52 44 150 378
2022/20233.119 233 351 362 494 274 704 26 188 362 17 75 33
2023/20244.032 72 112 208 151 206 2.509 101 101 21 134 272 145
2024/2025509 205 252 52 0 0 0 0 0 0 0 0 0
Totale 15.855